Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

…, JM Krzesinski, T Vanassche, G Girard, L Pliamm… - The Lancet, 2022 - thelancet.com
Background Resistant hypertension is associated with increased cardiovascular risk. The
endothelin pathway has been implicated in the pathogenesis of hypertension, but it is currently …

Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome

…, EM Lonn, A Milot, ME Pearce, L Pliamm… - JAMA …, 2021 - jamanetwork.com
Importance Inflammation promotes cardiovascular disease and anti-inflammatory treatment
reduces cardiovascular events in patients with chronic coronary syndrome. Chronic kidney …

[HTML][HTML] Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient-and rater-blinded, randomized, controlled trial

…, A Vasudev, P Dzongowski, L Pliamm… - Translational …, 2022 - nature.com
The pharmacological treatment of depression consists of stages of trial and error, with less
than 40% of patients achieving remission during first medication trial. However, in a large, …

Family physician-led, team-based, lifestyle intervention in patients with metabolic syndrome: results of a multicentre feasibility project

…, D Royall, A Tremblay, DM Mutch, L Pliamm… - … Open Access Journal, 2017 - cmajopen.ca
Background: Metabolic syndrome (MetS) is a medical condition with major complications
and health care costs. Previous research has shown that diet and exercise can improve and …

[HTML][HTML] Lot-to-lot immunogenicity consistency of the respiratory syncytial virus prefusion F protein vaccine in older adults

M Ferguson, A Murray, L Pliamm, L Rombo… - Vaccine: X, 2024 - Elsevier
Background Previous phase 3 studies showed that the AS01 E -adjuvanted respiratory
syncytial virus (RSV) prefusion F protein-based vaccine for older adults (RSVPreF3 OA) is well …

Correction: clinical utility of combinatorial pharmacogenomic testing in depression: a Canadian patient-and rater-blinded, randomized, controlled trial

…, A Vasudev, P Dzongowski, L Pliamm… - Translational …, 2022 - nature.com
The original version of this article unfortunately contained mistakes. To ensure the accuracy
of their article the authors would like to make the following corrections: Correction# 1 Page 5…

[PDF][PDF] Khursheed Jeejeebhoy MBBS PhD, Rupinder Dhaliwal RD, Daren K. Heyland MD, Roger Leung MSc, Andrew G. Day MSc, Paula Brauer PhD RD, Dawna …

MD Lew Pliamm - 2017 - academia.edu
Background: Metabolic syndrome (MetS) is a medical condition with major complications
and health care costs. Previous research has shown that diet and exercise can improve and …

[CITATION][C] T1397 A Novel, Oral 5HT3 Partial Agonist, DDP733, Improves Overall Response in Patients with Irritable Bowel Syndrome and Constipation (IBS-c): A …

…, D Ford, SC Ganguli, RP Reynolds, L Pliamm… - Gastroenterology, 2008 - infona.pl
… Reynolds, Lew Pliamm, Michael O'Mahony, Pierre Pare, Suhail Nurbhai, Brian Feagan,
Steven B. Landau …

[PDF][PDF] Andrew G. Day MSc, Paula Brauer PhD RD, Dawna Royall MSc RD, Angelo Tremblay MSc PhD, David M. Mutch PhD, Lew Pliamm MD, Caroline Rhéaume MD …

RD Rupinder Dhaliwal, DK Heyland - metabolicsyndromecanada.ca
Background: Metabolic syndrome (MetS) is a medical condition with major complications
and health care costs. Previous research has shown that diet and exercise can improve and …

[CITATION][C] Counselling Practices of Registered Dietitians in a Behaviour Change Intervention for Metabolic Syndrome

…, D Heyland, R Dhaliwal, L Pliamm… - … on the Science of …, 2016 - academyhealth.confex.com